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Divergent activity of the gonadotropin-
releasing hormone receptor gene promoter
among genetic lines of pigs is partially
conferred by nuclear factor (NF)-kB,
specificity protein (SP)1-like and GATA-4
binding sites
Emily A. McDonald1,2†, Jacqueline E. Smith1,3†, Rebecca A. Cederberg1 and Brett R. White1*
Abstract
Background: Binding of gonadotropin-releasing hormone (GnRH) to its receptor (GnRHR) on gonadotropes within
the anterior pituitary gland is essential to reproduction. In pigs, the GnRHR gene is also located near a genetic
marker for ovulation rate, a primary determinant of prolificacy. We hypothesized that pituitary expression of the
GnRHR gene is alternatively regulated in genetic strains with elevated ovulation rates (Chinese Meishan and
Nebraska Index) vs. standard white crossbred swine (Control).
Methods: Luciferase reporter vectors containing 5118 bp of GnRHR gene promoter from either the Control, Index
or Meishan swine lines were generated. Transient transfection of line-specific, full length, deletion and mutation
constructs into gonadotrope-derived αT3-1 cells were performed to compare promoter activity and identify regions
necessary for divergent regulation of the porcine GnRHR gene. Additionally, transcription factors that bind the
GnRHR promoter from each line were identified with electrophoretic mobility shift assays (EMSA).
Results: Dramatic differences in luciferase activity among Control, Index and Meishan promoters (19-, 27- and
49-fold over promoterless control, respectively; P < 0.05) were established. A single bp substitution (−1690) within a
previously identified upstream enhancer (−1779/−1667) bound GATA-4 in the Meishan promoter and the p52/p65
subunits of nuclear factor (NF)-κB in the homologous Control/Index promoters. Transient transfection of vectors
containing block replacement mutations of either the GATA-4 or NF-κB binding sites within the context of their
native promoters resulted in a 50 and 60 % reduction of luciferase activity, respectively (P < 0.05). Furthermore, two
single-bp substitutions in the Meishan compared to Control/Index promoters resulted in binding of the p52 and
p65 subunits of NF-κB and a specificity protein 1 (SP1)-like factor (−1235) as well as GATA-4 (−845). Vectors
containing the full-length Meishan promoter harboring individual mutations spanning these regions reduced
luciferase activity by 25 and 20 %, respectively, compared to native sequence (P < 0.05).
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Conclusions: Elevated activity of the Meishan GnRHR gene promoter over Control/Index promoters in αT3-1 cells is
partially due to three single nucleotide polymorphisms resulting in the unique binding of GATA-4 (−1690), the p52/p65
subunits of NF-kB in combination with a SP1-like factor (−1235), and GATA-4 (−845).
Keywords: GnRH receptor, Transcriptional regulation, NF-κB, GATA-4, SP1-like factor, Porcine, Single nucleotide
polymorphism, Ovulation rate, Anterior pituitary, Gonadotrope
Background
The hypothalamic decapeptide, gonadotropin-releasing
hormone (GnRH), binds to its cognate receptor (GnRHR)
on the surface of gonadotrope cells within the anterior pi-
tuitary gland, stimulating the synthesis and secretion of
the gonadotropins, follicle stimulating hormone (FSH)
and luteinizing hormone (LH) [1, 2]. The gonadotropins
subsequently act on the gonads to trigger secretion of ster-
oid hormones, which feedback at the level of the hypothal-
amus and anterior pituitary gland to regulate GnRH and
gonadotropin levels, respectively. Binding of GnRH to its
seven transmembrane, G-protein-coupled receptor acti-
vates multiple signal transduction cascades, ultimately
resulting in up-regulation of the genes that encode the
common α- and unique β-subunits of FSH and LH [3, 4]
as well as the GnRHR itself [5]. Therefore, the interaction
between GnRH and GnRHR represents a crucial point for
regulation of reproductive function in mammals. Further-
more, the porcine GnRHR gene is located on chromosome
8, in close proximity to a quantitative trait locus for ovula-
tion rate, a primary determinant of litter size [6]. Consist-
ent with this, a C/G substitution in the 3’ untranslated
region was shown to be significantly associated with ovu-
lation rate [7]. Consequently, the GnRHR gene represents
both a physiological and positional candidate for genes in-
fluencing prolificacy in pigs.
The GnRHR gene promoter has been extensively stud-
ied in the mouse, rat, human and sheep [8, 9]. In the
mouse, gonadotrope-specific expression is conferred by
500 bp of GnRHR gene promoter [10] comprised of
binding sites for steroidogenic factor 1 (SF1), activator
protein 1 (AP1) and a GnRHR activating sequence
(GRAS) [11, 12], although pituitary homeobox (Pitx)-1
and a member of the LIM homeodomain family, Lhx3,
have also been implicated [13, 14]. Additionally, protein
kinase C (PKC) activation of AP1 is critical for GnRH
responsiveness of the murine GnRHR gene promoter
[15], whereas the GRAS binding site acts in conjunction
with a downstream activin regulatory element to control
activin responsiveness [16]. Subsequent studies revealed
that the GRAS element binds a complex of transcription
factors including AP1, Smad3 and 4 and FOXL2, a mem-
ber of the forkhead family of transcription factors [17].
Furthermore, an enhancer element, sequence underlying
responsiveness to GnRH (SURG)-1 [18], binds octamer
transcription factor-1 (OCT1) and nuclear factor (NF)-Y
[19] for basal and maximal GnRH stimulation of GnRHR
gene transcription. A proximal homeodomain (Hbox)
binding motif also binds OCT1, indicating the transcrip-
tion factor acts at multiple TAAT sites to direct basal ex-
pression [20]. Interestingly, the CLOCK and BMAL1 drive
activity of the murine GnRHR promoter through their
interaction with E-box enhancer sequences [21]. The
importance of protein kinase A (PKA) signaling was also
illustrated by the role of a cAMP responsive element
(CRE) in activation of the GnRHR gene [22].
The rat and mouse GnRHR gene promoters appear
consistent, both containing SF1, AP1 and GRAS binding
sites [23]. However, the GRAS element in the rat
GnRHR promoter harbors an A→G bp alteration, dra-
matically reducing effectiveness of this binding site [24].
Furthermore, the rat promoter contains CRE-like and
SF1 adjacent protein (SAP) binding sites involved in basal
activity [25] and a GnRHR specific enhancer (GnSE) [24]
that interacts with GATA factors and the LIM-related fac-
tors, Isl-1 and Lhx3, to promote maximal basal activity
[25]. Although activity of the human GnRHR promoter in
cell lines of non-gonadotrope origin and in response to
hormones have been characterized [8], investigation into
gonadotrope-specific activity has only elucidated a SF1
binding site [26]. Additional studies revealed that AP1
confers down-regulation following GnRH stimulation [27]
and OCT1 serves as a strong constitutive repressor [28].
Elements conferring gonadotrope-specific expression of
the ovine GnRHR gene remain to be elucidated; however,
Duval and coworkers [29] reported a SF1 binding site that
mediates basal expression.
Our laboratory has previously shown that gonadotrope-
specific activity of the porcine GnRHR gene is partially
conferred by a SF1 binding site positioned within a 112-bp
upstream enhancer (−1779/−1667), as well as two add-
itional SF1 and one retinoid X receptor (RXR) binding
sites located within 315 bp of proximal promoter [30]. In
order to compare transcriptional regulation of the GnRHR
gene among pig lines with divergent ovulation rates, we
constructed luciferase reporter constructs containing
5118 bp of 5’ flanking sequence from three genetic lines of
swine: a Control white-crossbred line; a Nebraska Index
line selected for over 14 generations based on an index
of ovulation rate and embryonic survival [31]; and the
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Chinese Meishan breed, a line with increased prolifi-
cacy over white-crossbred lines, largely due to a greater
ovulation rate [32, 33]. Previously, our laboratory has
shown that anterior pituitary levels of GnRHR mRNA
were highest in Meishan, intermediate in Index and
lowest in Control [34]. Herein, we demonstrate differential
activity among these line-specific GnRHR promoters utiliz-
ing transient transfections assays in gonadotrope-derived
αT3-1 cells. In addition, we identified three bp substitutions
at −1690 (T→C), −1235 (C→G) and −845 (G→T) of
proximal promoter that allow GATA-4, the p52 and p65
subunits of nuclear factor (NF)-κB as well as a specificity
protein (SP)1-like factor, and GATA-4, respectively, to pref-
erentially bind the Meishan compared to Index or Control
GnRHR gene promoters.
Methods
Experiments involving the use of recombinant DNA
have been approved by the UNL Institutional Biosafety
Committee under Protocol ID # 12 entitled: Functional
Analysis of GnRHR I and II in Swine. The UNL Radi-
ation Safety Office has approved the use of isotopes in
the following experiments via AU License # I-387.
Materials
The antibody directed against the p65 subunit of NF-κB
(catalog no. PC137) was purchased from Calbiochem (La
Jolla, CA), the antibodies specific for the p52 subunit of
NF-κB (catalog no. 06–413), SP1 (catalog no. 07–645), SP3
(catalog no. 07–107) were from Upstate (Charlottesville,
VA), the specific antibodies for the p50 subunit of NF-κB
(catalog no. sc-114X), SP1 (catalog no. sc-59X), SP2 (cata-
log no. sc-643X), SP4 (catalog no. sc-13019X), GATA-1
(catalog no. sc-1234X), GATA-2 (catalog no. sc-9008X),
GATA-4 (catalog no. sc-1237) and normal rabbit IgG (cata-
log no. sc-2027) were obtained from Santa Cruz Biotech-
nology, Inc. (Santa Cruz, CA). For experiments using
EMSA, competitive oligonucleotides containing consensus
binding sites for activator protein (AP)2, NF-κB, SP1 or
GATA were synthesized by Integrated DNA Technologies
(Coralville, IA; Table 1).
Plasmids
Using primers specific for the porcine GnRHR gene
promoter originally isolated from the Control line [30],
we sequenced promoters from genomic DNA of the
Meishan and Index lines. Full-length GnRHR gene pro-
moters (−5118) from the three genetic pig lines were
sub-cloned into the pGL3 basic reporter vector (Pro-
mega Corp., Madison, WI). Studies involving constructs
containing progressively less 5’ flanking sequence of the
GnRHR gene promoter for all three lines of pigs were
generated by restriction endonuclease digestion of vectors
containing the full-length GnRHR gene promoter for
each line and subsequent intramolecular ligation of
the remaining vector backbone (PvuII, SpeI and BlpI).
The promoter “swap” vectors containing full-length
GnRHR gene promoter with the region from the −1915
to −1431 bp exchanged between Control and Meishan
promoters was constructed from vectors containing
5118 bp of native sequence. Restriction endonuclease di-
gestion of the internal 484 bp and subsequent ligation of
the corresponding region for the promoter of the other
line of swine was performed. Overlap extension PCR mu-
tagenesis was performed through two rounds of PCR in
order to specifically mutate the binding element of interest
[35]. The first round of PCR utilized primers replacing the
binding site of interest with a restriction site, and the sec-
ond round used product from the first round as template
to anneal and replicate the mutated element and flanking
sequence (Table 2). The mutation of the SF1 binding sites
located at −179/−171 in each of the promoters was per-
formed with the same set of primers and generated a NotI
restriction enzyme site. The −MμGATAUEpGL3, −MμNF-
κBpGL3, −MμSP1pGL3 and −MμGATA4pGL3 plasmids
were composed of 5118 bp of 5’ flanking sequence for
the Meishan GnRHR gene with individual elements
mutated to contain either a SpeI (−MμGATAUEpGL3),
NsiI (−MμNF-κBpGL3), SpeI (−MμSP1pGL3) or PstI
(−MμGATA4pGL3) site. The −Mμ1240pGL3 plasmid
contained a double mutation of the NF-κB and SP1 sites
discussed above. The −CμNF-κBpGL3 plasmid was made
by substituting the NF-κB site for EcoRI. To verify that the
correct mutations had been introduced, vectors were se-
quenced before use in transient transfection experiments.
The vector used as a control for transfection efficiency in
all experiments contained the Rous Sarcoma Virus (RSV)
Table 1 Sense strand of EMSA oligosa
Name Sequence
AP2 consensusb 5’-GATCGAACTGACCGCCCGCGGCCCGT-3’
GATA consensusb 5’-CACTTGATAACAGAAAGTGATAACTCT-3’
GR consensusb 5’-AGAGGATCTGTACAGGATGTTCTAGAT-3’
NF1 consensusb 5’-TTTTGGATTGAAGCCAATATGATA-3’
NF-κB consensusb 5’-AGTTGAGGGGACTTTCCCAGGC-3’
SP1 consensusb 5’-AATCGATCGGGGCGGGGCGAG-3’
C/I −855/−835c 5’-GCATACAAAGGGATATAAACA-3’
M −853/−833c 5’-GCATACAAAGTGATATAAAC-3’
C/I −1245/−1225c 5’-AGCTTCCTCACGGCCTGGATG-3’
M −1243/−1223c 5’-AGCTTCCTCAGGGCCTGGATG-3’
C/I −1700/−1680c 5’-AACCCCATATTTCCACTGAGA-3’
M −1676/−1656c 5’-AACCCCATATCTAGGCACTAA-3’
aThe complement strand was annealed for each oligonucleotide prior to use in
gel shift assays
bAP2, activator protein 2; GR, glucocorticoid receptor; NF1, nuclear factor 1;
NF-B, nuclear factor-κB; SP1, specificity protein 1
cBase pair substitutions between the different breed promoters are in bold italics
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promoter fused to the cDNA encoding β-galactosidase
(RSV-βgal, Stratagene, La Jolla, CA). A midi plasmid prep-
aration kit (Qiagen, Valencia, CA) was used to isolate
transfection quality DNA.
Cell culture and transient transfections
Cultures of αT3-1 cells (Dr. Pam Mellon, Salk Institute,
La Jolla, CA) were maintained at 37 °C in a humidified
5 % CO2 in air atmosphere. The αT3-1 cells were cul-
tured in high-glucose DMEM (4.5 g/L; Mediatech, Hern-
don, VA) supplemented with 5 % fetal bovine serum, 5 %
horse serum, 2 mM glutamine, 100 U/ml penicillin and
100 μg/ml streptomycin sulfate (Gibco, Grand Island,
NY). Transient transfections were carried out using a
liposome-mediated protocol (Fugene6, Roche Diagnos-
tics Corp., Indianapolis, IN) according to manufacturer’s
instructions. Briefly, 2 × 106 cells were plated in 6-well
culture dishes 1 d prior to transfection. Cells were trans-
fected with a 3:1 Fugene6 to DNA ratio. A total of 1 μg
of DNA, 0.9 μg of luciferase test vector and 0.1 μg of
RSV-βgal control vector were used per well. Approxi-
mately 20–24 h post-transfection, cells were washed
twice with ice-cold PBS and harvested with 200 μl of
lysis buffer [100 mM potassium phosphate (pH 7.8),
0.2 % Triton X-100 and 1 mM dithiothreitol (DTT)]. Ly-
sates were cleared by centrifugation at 14,000 X g for
2 min at 4 °C. Lysates (20 μl) were immediately analyzed
according to manufacturer’s instructions for both luciferase
(Promega Corp.) and β-gal (Applied Biosystems, Bedford,
MA) activity using a Wallac Victor2 microplate reader
(PerkinElmer Life Sciences, Boston, MA). Luciferase
values were divided by β-gal values to adjust for transfec-
tion efficiency. The raw data for all transfections utilized
in this study have been included (Additional file 1).
EMSA
Nuclear protein extracts were obtained from approxi-
mately 2.8 × 108 αT3-1 cells using the NE-PER® Nuclear
and Cytoplasmic Extraction Reagents Kit (Pierce Bio-
technology, Rockford, IL). The nuclear extracts were
treated with protease (catalog no. P8340; Sigma Chemical
Co., St. Louis, MO) and phosphatase (catalog no. 524625;
Calbiochem, La Jolla, CA) inhibitor cocktail solutions to
prevent enzymatic degradation of proteins. The amount of
protein present in the extracts was determined using
bicinchoninic acid (BCA assay, Pierce Biotechnology). Oli-
gonucleotides were end-labeled with [γ-32P]ATP using T4
polynucleotide kinase (Fermentas Inc., Hanover, MD) and
purified using sephadex G-25 spin columns (Amersham
Biosciences Corp., Piscataway, NJ). EMSAs were com-
pleted through incubation of nuclear extracts (5 μg) in
20 μl reactions containing 4 μl of Dignam D buffer
(20 mM HEPES, 20 % glycerol, 0.1 M potassium chloride,
0.2 mM EDTA and 0.5 mM DTT), 1 mM DTT, 2 μg of
poly(dI•dC) (Amersham Biosciences) and, where indi-
cated, a rabbit polyclonal antibody directed against the
p65 (Calbiochem), p52 (Upstate, Lake Placid, NY), or
p50 (Santa Cruz Biotechnology) subunits of NF-κB;
Table 2 Primers used to generate reporter vectors
Name Sequence
−5118pGL3 F 5’-CAGACAATTAGATTCCAGGGC-3’
Promoter R 5’-TCCTTCCCCAACTGATGTAG-3’
μSF1pGL3 Fa 5’-AAGTACACAAAACAAGTTGCGGCCGGCTCTTTCACATTAAATATA-3’
proximal A OF 5’-GTTATGTGGAAGAGCCGGTG-3’
proximal OR 5’-CTTTATGTTTTTGGCGTCTTCC-3’
MμGATAUEpGL3Fa 5’-TTGCAGAAACCTAACCCCACTAGTAGGCACTAATCCAGTGTC-3’
CμNF-κBpGL3 Fa 5’-TTGGCTTGCAGAAACCTAGAATTCTATTTCCACTGAGAGCAA-3’
distal OF 5’-CAGAGAATGCTATTGCTCTC-3’
distal OR 5’-GTGTAAGTGTTGGAACCACATC-3’
Mμ1240pGL3 Fa 5’-CATAGCACCAAGGAAGCTATGCATACTAGTGGATGATACTGTGTGCAG-3’
proximal B OF 5’-AGGCACTAATCCAGTGTCTGC-3’
proximal OR 5’-CTTTATGTTTTTGGCGTCTTCC-3’
MμSP1pGL3 Fa 5’-ACCAAGGAAGCTTCCTCAACTAGTGGATGATACTGTGTGCAG-3’
MμNF-κBpGL3 Fa 5’-CATAGCACCAAGGAAGCTATGCATGGGCCTGGATGATACTGT-3’
MμGATA4pGL3 Fa 5’-ATTAGATTGCATACAAAGCTGCAGAAACAAATATTCATATTA-3’
proximal C OF 5’-TACTCCTCTTGATTTCTGACTC-3’
proximal OR 5’-CTTTATGTTTTTGGCGTCTTCC-3’
aBlock replacement mutation reporter vectors were generated with outer forward (OF) or outer reverse (OR) primers as described in the Methods. The proximal
OR resides in pGL3 3’ of the insert. Underlined bases indicate the new restriction enzyme digest site that replaced the transcription factor binding site in the
native sequence
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GATA-1, -2 and -4 (Santa Cruz Biotechnology); SP1
(Upstate), SP1, SP2, SP3 and SP4 (Santa Cruz Biotech-
nology) or an equal mass of rabbit IgG (Santa Cruz
Biotechnology) at 4 °C for 2 h. Following incubation,
radiolabeled probe (100,000 cpm) and 50-fold molar
excess of either homologous or heterologous unlabeled
competitor was added. Where indicated, 50-fold molar
excess of unlabeled oligonucleotides containing consensus
binding sequences for AP2, NF-κB, SP1, glucocorticoid re-
ceptor (GR), nuclear factor (NF)-1 or GATA-4 were also
added. The final reactions were incubated at 25 °C for
20 min before bound probe was separated from free at
30 mA for 1.5 h on a 5 % polyacrylamide gel that had been
prerun at 100 V for 1 h in 1X TGE [25 mM Tris (pH 8.3),
190 mM glycine and 1 mM EDTA]. Gels were transferred
to blotting paper, dried, and exposed to Biomax MS film
(Eastman Kodak Co., Rochester, NY) for 20–24 h at −80 °C
before being developed.
Western blot
Nuclear proteins from αT3-1 cells were extracted using
the Nuclear Complex Co-IP kit from Active Motif
(Carlsbad, CA), quantitated with a BCA protein assay kit
(Pierce) and stored at −80 °C. Protein samples (40 μg)
were boiled for 5 min in a 2X reducing loading buffer
(130 mM Tris pH 6.8, 4 % SDS, 0.02 % Orange G, 20 %
glycerol, 100 mM DTT), cooled to room temperature
(RT) and loaded onto an SDS polyacrylamide gel (PAGE)
with a 5 % stacking and 10 % resolving gel. Gels were
run at 40 mA for approximately 90 min and electropho-
resed proteins were transferred to polyvinylidene difluor-
ide (PVDF, Immobilon -FL, Millipore, Billerica, MA)
membrane with a semi-dry electroblotter (Panther, Owl
Separation Systems, Portsmouth, NH). Briefly, PVDF
membrane was pre-wetted in 100 % methanol and
soaked with the gel in transfer buffer (25 mM Tris
pH 8.3, 192 mM glycine, 0.1 % SDS, 20 % methanol) for
15 min. The proteins were transferred at 200 mA for
1 h. Membranes were blocked with StartingBlock™ TBS
buffer (Pierce) for 30 min at room temperature with agi-
tation. Incubation of primary antibodies directed against
the p50 (Santa Cruz Biotechnology), p52 (Upstate) and
p65 (Calbiochem) subunits of NF-κB were performed in
StartingBlock™ TBS buffer supplemented with 0.05 %
Tween-20. Antibodies were used at 1:500 (p50) or
1:5000 (p52 and p65) dilutions. Blots were incubated
with primary antibody overnight at 4 °C with gentle shak-
ing. After incubation, the blots were washed four times
with TBS-T (20 mM Tris pH 7.6, 137 mM sodium chlor-
ide, 0.1 % Tween-20). Each wash was performed for 5 min
with gentle agitation. The secondary antibody, Alexa Fluor
680 goat anti-rabbit IgG (A21076, Invitrogen, Carlsbad,
CA) was diluted 1:15,000 in StartingBlock™ TBS buffer
(Pierce) supplemented with 0.01 % SDS and 0.05 %
Tween-20. The incubation was performed at RT for 1 h
with gentle shaking. Blots were washed four times with
TBS-T for 5 min with gentle agitation. After a final rinse
with TBS, blots were scanned on the 700 channel of the
Odyssey Infrared Imaging System (LI-COR, Lincoln, NE)
following manufacturer’s instructions.
Statistical analysis
Data were analyzed using the general linear models
(GLM) procedure of the Statistical Analysis System
(SAS, version 8.2, Cary, NC). To control for transfection
efficiency, the arbitrary light value for each replicate was
divided by the respective β-gal value. These values were
then divided by the mean of the empty vector and re-
ported as fold activity over pGL3. All transfections were
performed a minimum of three times, with samples in
triplicate using different plasmid preparations for each
transfection. Individual values from all the replicates
were used to generate the mean ± SEM. Comparisons
between pGL3 and test vectors were evaluated with
Dunnett’s t-test. Least squares means for luciferase activ-
ity were compared among test vectors using least signifi-
cant differences.
Results
The −5118 bp Control, Index and Meishan GnRHR
promoters display divergent activity in αT3-1 cells, which
is maintained upon promoter reduction to −1915 bp
Transient transfection of plasmids containing the full-
length GnRHR gene promoter (−5118) for either the
Control (−C5118pGL3), Index (−I5118pGL3) or Meishan
(−M5118pGL3) lines into gonadotrope-derived αT3-1
cells established dramatic increases (P < 0.05) in luciferase
activity for Control (19-fold), Index (27-fold) and Meishan
(49-fold) constructs over promoterless control (Fig. 1).
These differences represented a 1.5- and 2.7-fold increase
in luciferase activity for vectors containing the Index and
Meishan promoters, respectively, over the corresponding
plasmid containing the promoter from the Control line.
As a positive control, we also included a luciferase re-
porter vector containing 600 bp of the mouse GnRHR
promoter (−m600pGL3) as Clay and coworkers [11] dem-
onstrated robust activity of this construct in αT3-1 cells.
Interestingly, the 49-fold increase in luciferase activity of
the Meishan reporter vector compared to promoterless
controls was higher (P < 0.05) than that of the construct
containing the mouse promoter (39-fold; Fig. 1). In sum-
mary, the differential promoter activity among the three
swine lines indicates the use of divergent mechanisms for
transcriptional regulation of the GnRHR gene.
Previous work in our laboratory indicated that gona-
dotrope-specific expression of the porcine GnRHR gene
was conferred by elements located within 1915 bp of
proximal promoter [30]. To determine if this region
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contained elements conferring line-specific expression,
we reduced the 5’ flanking region for all three pig lines
from −5118 to −1915 bp. Transient transfection of plas-
mids containing either −5118 (described above) or −1915
GnRHR promoters for the Meishan (−M1915pGL3),
Index (−I1915pGL3) and Control (−C1915pGL3) lines re-
sulted in maintenance of significant differences in lucifer-
ase activity among lines (Fig. 1). Therefore, the elements
conferring line-specific expression of the porcine GnRHR
gene reside within 1915 bp of proximal promoter.
Sequence alignment of the Control, Index and Meishan
GnRHR promoters identified polymorphisms at several
locations within −1915 bp of promoter
Alignment of the −1915 bp Control and Meishan pro-
moters identified 10 single bp changes and a single bp
deletion (Table 3). Additionally, the Meishan promoter
contained a 2-bp deletion within the proximal promoter
and a 22-bp deletion within an upstream enhancer re-
gion previously identified as important for basal activity
of the GnRHR promoter in gonadotropes [30]. Five
single bp changes were noted in the comparison of the
Index and Control promoters. Jiang and colleagues
previously published 1154 bp of porcine GnRHR gene
promoter (GenBank AF227685) as part of a QTL study
evaluating polymorphisms associated with altered
numbers of corpora lutea in European Large White
and Meishan breeds [7]; documenting the TG deletion
and single bp substitutions at −562 and −845 bp in the
Meishan promoter. Further, alignment of the genomic
clone Sscrofa 10.2, which is from a mixed breed sample, to
the three breeds in this study indicated that the mixed
breed sequence was more similar to the Meishan than
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Fig. 1 Reporter constructs containing GnRHR promoters from Meishan, Index and Control swine lines exhibit divergent activity. αT3-1 cells were
transiently transfected with luciferase (LUC) reporter vectors containing either 5118 or 1915 bp of GnRHR promoter for the Meishan (−M5118pGL3 and
−M1915pGL3), Index (−I5118pGL3 and −I1915pGL3) and Control (−C5118pGL3 and −C1915pGL3) lines of swine, 600 bp of the mouse GnRHR promoter
(−m600pGL3), or promoterless control (pGL3). The −m600pGL3 vector was included as a positive control because it has been shown to have robust
activity in this cell line. Unique letters within vectors containing the same portion of 5’ flanking sequence (−5118 or −1915) for each swine line
(brackets) indicate values that are significantly different from one another (P < 0.05). An asterisk indicates a mean significantly different from
all others (P < 0.05)
Table 3 Base changes between lines within the −1915 bp
promotersa
Line Changea Locationa
Meishan TG deletionb −233/−232
Meishan C to Tb,c −562
Index A to G −605
Index T to C −651
Meishan G to Tb −845
Index T to C −1027
Meishan T to G −1094
Index C to T −1110
Meishan A to Gc −1211
Meishan C to Gc −1235
Meishan A to Cc −1450
Meishan C to Ac −1615
Meishan A to Gc −1639
Meishan T to Cc −1690
Meishan 22 bp deletionc −1688/−1667
Index A to T −1727
Meishan C deletionc −1738
Meishan A to G −1742
aRelative to the Control line sequence
bThese base pair substitutions were also noted in the GenBank
sequence AF227685
cThe Sscrofa 10.2 genomic clone NC_010450.3 had the Meishan base pair
substitutions at these locations. At −1219 the genomic clone has a G to A
substitution compared to the Control line sequence
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either the Index or Control. Nine of the 13 observed
Meishan polymorphisms aligned with the Sscrofa 10.2
sequence.
Differential GnRHR promoter activity among genetic lines
is not attributable to a SF1 binding site, an essential
element to basal activity of the promoter in αT3-1 cells
Previously, our laboratory identified a SF1 binding site
located −179/−171 upstream of the translational start
site as a necessary member of the gonadotrope-
specific promoter for the porcine GnRHR gene [30].
Luciferase reporter constructs harboring a block re-
placement mutation of this gonadotrope specific elem-
ent (GSE) within the context of the −5118 bp
promoter completely blocked luciferase activity com-
pared to vectors containing the −5118 bp promoter
alone. Such findings led us to investigate the role of
this SF1 binding site with regard to line divergence for
GnRHR gene promoter activity. Transient transfection
of αT3-1 cells with reporter constructs containing the
mutated SF1 binding site within the context of the
full-length promoter completely ablated (P < 0.05)
GnRHR promoter activity for all three lines of pigs
(Fig. 2). Therefore, this SF1 binding site is critical for
transcriptional activity of the porcine GnRHR pro-
moter in all three genetic lines. However, these data
also indicate that this site is not involved in line-
dependent activity of the GnRHR gene promoter.
The region between −1915/−1431 of the porcine GnRHR
gene promoter is not alone responsible for line divergent
promoter activity
Upon sequence comparison of the −1915 promoters for the
three lines, we identified a 22 bp deletion (−1682/−1661)
accompanied by a single bp substitution (−1684) in the
Meishan promoter compared to either the Index or Control
promoters. Based on the sequence divergence between the
Meishan and Index/Control promoters within the −1915/
−1431 region of proximal GnRHR promoter, we performed
a promoter “swap” experiment, in which the 484 bp region
between −1915/−1431 of the Control and Meishan pro-
moters were swapped within the context of the native
full-length promoter. Although luciferase activity of the
Meishan promoter decreased (P < 0.05) when manipulated
to contain 484 bp of the Control promoter, activity of the
Meishan GnRHR gene promoter maintained much higher
levels than the full-length Control promoter (Fig. 3). Alter-
natively, activity of the Control promoter containing
484 bp of Meishan promoter sequence remained at signifi-
cantly lower levels than the full-length Meishan promoter
(Fig. 3). Therefore, the −1915/−1431 region does not ap-
pear to contain the element(s) responsible for divergence
in GnRHR gene promoter activity between Meishan and
Index/Control lines of swine.
Enhanced activity of the Meishan GnRHR gene promoter
is diminished upon reduction of the 5’ flanking region
to −1004 bp
We performed transient transfections in αT3-1 cells
with plasmids containing sequential 5’ deletions of the
−1915 promoter (−1915pGL3, −1431pGL3, −1004pGL3
and −524pGL3) for all three pig lines (Meishan, Index
and Control). Removal of approximately 500 bp from
the −1915 promoter for Meishan, Index and Control
swine maintained genetic line divergence for luciferase
activity (Fig. 4). However, reduction of 5’ flanking se-
quence from −1431 to −1004 eliminated the enhanced
promoter activity for the Meishan line (P < 0.05) compared
-CµSF1pGL3
-IµSF1pGL3
-MµSF1pGL3
-C5118pGL3
-I5118pGL3
-M5118pGL3
pGL3
LUCX
LUC
LUC
LUC
LUC
LUC
LUC
X
X
Fold activity over pGL3
0 2 4 6 8 10 12 14 16 18 20
*
*
*
Meishan
Index
Control
Fig. 2 A SF1 binding site is crucial for transcriptional activity of the GnRHR gene in all three genetic lines of swine. Luciferase (LUC) reporter
vectors containing block replacement mutation of the SF1 binding site in the context of the full-length promoter were constructed for all three
lines of swine (Meishan, −MμSF1pGL3; Index, −IμSF1pGL3; Control, −CμSF1pGL3). These vectors, along with vectors containing full-length native
GnRHR promoter for Meishan (−M5118pGL3), Index (−I5118pGL3) and Control (−C5118pGL3) lines of swine were transiently transfected into
αT3-1 cells. An asterisk indicates means that are greater than promoterless control (pGL3; P < 0.05)
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to the Index promoter, although luciferase activity
for −M1431pGL3 and −I1431pGL3 were still greater
(P < 0.05) than the corresponding Control promoter
(Fig. 4). This suggests the presence of an element(s)
partially responsible for line-specific promoter activity
within the −1431/−1004 region of the porcine GnRHR
gene promoter. We also noted that further reduction of
the GnRHR promoters for each line to −524 bp eliminated
differences in luciferase activity among the lines (P < 0.05),
inferring that line-specific elements could reside be-
tween −1004/−524.
A T→ C bp substitution at −1690 confers divergent
binding between the Meishan and Control/Index GnRHR
gene promoters
Sequence analysis identified a single bp alteration located
within the upstream enhancing region at −1690 bp of
proximal promoter between the Meishan and homologous
Control/Index promoters (Fig. 5a). Electrophoretic mo-
bility shift assays utilizing αT3-1 nuclear extracts and
radiolabeled oligonucleotides spanning the bp substitu-
tion (−1690) between the Meishan and Control/Index
promoters revealed a specific binding complex for both
swine lines (Fig. 5b). Sequence analysis of this region
identified potential NF-κB and GATA elements in the
Meishan and Control/Index promoters. Addition of
antibodies directed against the p52 and p65 subunits of
NF-κB resulted in a supershift of the DNA:protein
complex for the Control/Index oligonucleotide (Fig. 5c).
However, the specific binding complex associated with
the Meishan oligonucleotide was supershifted by an
antibody specific for GATA-4 (Fig. 5c). Therefore, the
single bp alteration in the Meishan promoter forms a
GATA element that allows GATA-4 binding instead of
the p52 and p65 subunits of NF-κB which bind to the
Control/Index promoters.
Fold activity over pGL3
LUC
LUC
LUC
LUC
LUC
-M5118pGL3
-C5118pGL3
pGL3
-M(C)5118pGL3
-C(M)5118pGL3
0 10 20 30 40 50 60
a
b
b
c
d
Meishan
Control
Fig. 3 Divergence of GnRHR promoter activity between lines is not alone conferred by the −1915/−1431 bp region. Transient transfection of
αT3-1 cells with GnRHR gene promoter “swap” luciferase (LUC) reporter constructs for Meishan and Control lines of swine was performed.
The −M(C)5118pGL3 vector is the full-length Meishan reporter construct with the 484 bp region from −1915 to −1431 bp replaced with the
Control promoter sequence from that region, whereas the −C(M)5118pGL3 vector is the reverse. Unique letters indicate means different from one
another (P < 0.05)
0 5 10 15 20 25 30
Fold activity over pGL3
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c
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-M524pGL3
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Fig. 4 Reduction of the Meishan GnRHR promoter to −1004 bp eliminates its enhanced activity. Luciferase (LUC) reporter vectors containing
either 1915, 1431, 1004 or 524 bp of proximal promoter for the GnRHR gene from Meishan, Index and Control lines of swine or promoterless
control (pGL3) were transiently transfected into αT3-1 cells. Unique letters within vectors containing the same portion of 5’ flanking sequence
(−1915, −1431, −1004 or −524) for each swine line (brackets) indicate values that are significantly different from one another (P < 0.05)
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Block replacement mutations of both the GATA-4 and
NF-κB binding sites in the Meishan and Control/Index
promoters, respectively, attenuated luciferase activity
Transient transfections of αT3-1 cells with luciferase re-
porter vectors containing either the native, full-length
Meishan (−M5118pGL3) and Control (−C5118pGL3)
promoters, block replacement mutations of the GATA-4
(−MμGATAUE-4pGL3) and NF-κB (−CμNF-κBpGL3)
binding sites within the context of their respective full-
length promoter or promoterless control (pGL3) were
performed. Reporter vectors containing the block re-
placement mutation of the GATA-4 binding site
(−MμGATAUEpGL3) resulted in approximately a 50 %
reduction in luciferase activity (P < 0.05) compared to
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Fig. 5 The −1690 bp substitution in the Meishan promoter binds GATA-4, whereas the Control/Index promoters bind NF-κB. a Oligonucleotide
probes (5’ to 3’) were synthesized containing sequence flanking a naturally occurring point mutation at −1690 of the Control/Index (C/I −1700/−1680)
or −1666 of the Meishan (M −1676/−1656) promoter. Underlines within each DNA probe represent the nucleotide substitution between lines
and putative NF-κB (ACCCCA; Blue) and GATA-4 (ATATCT; Red) elements identified by sequence analysis are highlighted. b EMSAs were
performed with αT3-1 nuclear extracts and radiolabeled oligonucleotides spanning the −1690 bp substitution between the Control/Index and
Meishan (−1666 bp) swine lines. To determine the specificity of the DNA:protein complex, 50-fold molar excess of either unlabeled homologous
or heterologous DNA were added (specific complexes indicated by arrows). c To assess which specific proteins comprised the DNA:protein complex
binding to the oligonucleotide spanning the substitution at −1690 bp of the Control promoter (−1666 bp of the Meishan promoter), antibodies directed
against the p65, p50, and p52 subunits of NF-κB, GATA-1, -2 and -4, or an equal mass of rabbit IgG were added (supershifts indicated by arrows)
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the native Meishan promoter (Fig. 6). Further, αT3-1
cells transfected with the reporter vectors containing the
block replacement mutation of the NF-κB binding site
(−CμNF-κBpGL3) reduced luciferase activity (P < 0.05)
by approximately 60 % compared to cells containing the
native Control promoter (Fig. 6). Thus, this single bp
substitution contributes to the line-specific activity of
the porcine GnRHR gene promoter.
A C→ G bp substitution at −1235 promotes binding of
transcription factors unique to the Meishan GnRHR
promoter
Sequence analysis of the −1431/−1004 region of prox-
imal promoter revealed five single-bp substitutions
among the swine lines. EMSAs using radiolabeled oligo-
nucleotides spanning each of these substitutions (data
not shown) revealed that the C→G alteration at −1235,
relative to the translational start site (Fig. 7a), allowed
binding of nuclear proteins from αT3-1 cells to the
oligonucleotide from the Meishan promoter, whereas the
oligonucleotide representing the Control/Index pro-
moter failed to bind protein (Fig. 7b). Competition with
oligonucleotides composed of the consensus binding se-
quences for AP2, NF-κB, and SP1 resulted in ablation of
binding by the NF-κB and SP1 consensus oligonucleo-
tides (Fig. 7b). Inclusion of antibodies directed against
the p52 and p65 subunits of NF-κB in EMSAs with the
oligonucleotide containing the bp substitution at −1235 bp
of the Meishan GnRHR gene promoter revealed a
supershift of the DNA-protein complex, whereas the
addition of an antibody specific for the p50 subunit of
NF-κB did not affect complex migration (Fig. 7c). Fur-
ther, addition of antibodies directed against SP1 (from
two separate commercial vendors), SP2, SP3 and SP4
did not result in a supershift (Fig. 7c). Western blot
analysis of αT3-1 nuclear extracts confirmed that the
p52 and p65 subunits of NF-κB are present, whereas no
protein was detected for the p50 subunit (Fig. 8). Thus,
the p52 and p65 subunits of NF-κB are members of the
protein complex binding to the −1240/−1230 region of
the Meishan promoter. In addition, a factor capable of
binding to the consensus SP1 oligonucleotide is likely
another member comprising the Meishan-specific bind-
ing complex within this promoter region.
Block replacement mutations of the NF-κB and SP1 binding
sites located between −1240/−1230 of 5’ flanking region
reduce activity of the Meishan GnRHR promoter
Luciferase reporter vectors containing block replace-
ment mutations of the binding elements for NF-κB
(−MμNF-κBpGL3), SP1 (−MμSP1pGL3), or both
(−Mμ1240pGL3) within the context of the full-length
promoter from the Meishan line were transiently
transfected into αT3-1 cells to determine the importance
of these binding elements to overall activity of the
Meishan GnRHR promoter. All three vectors containing
block replacement mutations reduced luciferase activity
(P < 0.05) approximately 25 % when compared to the
vector containing the native full-length Meishan pro-
moter (Fig. 9). Despite the decreased luciferase activity
for the vectors containing block replacement mutations,
they appear higher (33- to 39-fold over promoterless con-
trol) than the values obtained for the vector containing
the full-length Control promoter (−C5118pGL3) in Fig. 1
(19-fold over promoterless control). This suggests that
while this region confers increased promoter activity of
the Meishan GnRHR promoter, it acts synergistically with
other elements(s) located within the Meishan proximal
promoter.
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Fig. 6 Mutation of GATA-4 and NF-κB elements indicate those sites are functionally relevant to promoter activity. To confirm the importance of
the GATA-4 binding site within the Meishan promoter and the NF-κB element within the Control/Index promoters, block replacement mutations
of each binding site were constructed within the context of their respective full length promoter. Transient transfection of αT3-1 cells with
luciferase (LUC) reporter vectors containing both full-length promoters (−M5118pGL3 and −C5118pGL3), block replacement mutations of the
GATA-4 (−MμGATAUEpGL3) and NF-κB (−CμNF-κBpGL3) elements or promoterless control (pGL3) were performed. Differences between
vectors are indicated by bars with unique letters (P < 0.05)
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A third bp substitution (G→ T) located at −845 bp
confers divergent GATA-4 binding to the Meishan GnRHR
promoter
Examination of the sequence between −1004/−524 of
proximal promoter indicated four additional sequence
differences when comparing the three lines of swine. To
determine if these single-bp substitutions resulted in
binding differences among lines, EMSAs were performed
with radiolabeled oligonucleotides spanning the bp al-
terations. A bp substitution (G→ T) located at −845
(Fig. 10a), relative the translational start site, resulted
in binding of nuclear extracts from αT3-1 cells for the
Meishan but not the Control/Index oligonucleotides
(Fig. 10b). The specific complex was abrogated by
addition of unlabeled oligonucleotide containing consen-
sus binding sites for GATA (Fig. 10b). With the addition
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of antibodies specific for GATA-1, GATA-2, and GATA-4
or an equal mass of rabbit IgG, a supershift of the complex
was observed with the GATA-4 antibody (Fig. 10c). Thus,
a single-bp substitution (G→T) at −845 bp of the
Meishan GnRHR promoter results in formation of a
GATA-4 binding site.
Block replacement mutation of the GATA-4 binding site
at −845/−840 of 5’ flanking region reduces activity of the
Meishan GnRHR promoter
Luciferase reporter vectors were constructed containing
a block replacement mutation of the GATA-4 binding site
within the context of the full-length Meishan promoter
(−MμGATA4pGL3). Transient transfections were per-
formed in the αT3-1 cell line with reporter vectors con-
taining the full-length Meishan promoter (−M5118pGL3),
−MμGATA4pGL3, and promoterless control (pGL3). The
GATA-4 block replacement mutation reduced luciferase
activity (P < 0.05) approximately 20 % compared to the
full-length Meishan promoter (Fig. 11). Thus, the en-
hanced activity of the Meishan GnRHR gene promoter is
partially due to this unique GATA-4 binding site. Consist-
ent with our previous results, the values obtained for the
−MμGATApGL3 vector (45-fold over promoterless con-
trol) were higher than those established for the full-length
Control promoter (19-fold over promoterless control;
Fig. 1). Therefore, this element, along with the two already
described (NF-κB and SP1), do not fully explain the diver-
gent Meishan GnRHR promoter activity.
Discussion
Here, we have demonstrated a dramatic variance in ac-
tivity among reporter vectors containing GnRHR pro-
moters from the Control, Index and Meishan lines of
pigs using transient transfections in the gonadotrope-
derived αT3-1 cell line. Divergent activity of the Control,
Index, and Meishan promoters illustrates a potential al-
teration in the mechanisms underlying transcriptional
regulation of the porcine GnRHR gene among genetic
strains. Ultimately, differential regulation of GnRHR
gene expression may be correlated with divergent ovu-
lation rates as well as other reproductive traits ob-
served among the Control, Index and Meishan pig
lines. This characteristic difference in activity among
pig strains was lost after promoter constructs were reduced
from −1431 to −1004 bp of 5’ flanking region, inferring that
the element(s) responsible for the elevated luciferase
activity of the Meishan promoter construct is located
within the proximal 1431 bp of GnRHR promoter.
Within gonadotrope-derived cell lines, the majority of
elements responsible for basal and hormonally-induced
expression of the GnRHR gene in other species are lo-
cated within 1000 bp of proximal promoter [10–19,
22–28, 36, 37], although placental-, granulosa/luteal
cell- and neuronal-specific promoters have been identi-
fied further upstream in the human [38–40]. On the
other hand, the spatial arrangement of the porcine
GnRHR promoter is somewhat unique because it re-
quires approximately 1800 bp of 5’ flanking sequence
for basal activity in αT3-1 cells [30]. Despite the fact
that the elements which confer line-specific activity of
the porcine GnRHR promoter lie further upstream than
1000 bp, they still remain within the boundaries of the
gonadotrope-specific promoter.
Transcriptional regulation of the GnRHR gene in
different species is achieved through a variety of
mechanisms and a number of different transcription
factors [8, 9]. One of the most characterized mecha-
nisms for transcriptional regulation of the GnRHR
gene involves the orphan nuclear receptor, SF1, known
to be vital for gonadotrope-specific expression of the
GnRHR gene in the human [26], mouse [11], rat [24],
sheep [29] and pig [30]. SF1 binding is also known to
confer expression of the gonadotropin subunit genes
within gonadotrope cells [41–43]. Previously, our la-
boratory demonstrated that three SF1 binding sites are
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Fig. 9 Mutations of the NF-κB, SP1 or both elements reduce activity of Meishan reporter constructs. Luciferase (LUC) reporter vectors containing
either the native, full-length Meishan GnRHR gene promoter (−M5118pGL3), block replacement mutations of the NF-κB (−MμNF-κBpGL3), SP1
(−MμSp1pGL3) or a combination of the two (−Mμ1240pGL3) binding sites within the context of −M5118pGL3, or promoterless control (pGL3)
were transiently transfected into αT3-1 cells. Unique letters indicate means that are significantly different from one another (P < 0.05)
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involved in transcriptional regulation of the porcine
GnRHR gene promoter in αT3-1 cells. In reporter assays,
mutation of the proximal SF1 binding site at −179/−171 bp
resulted in complete ablation of promoter activity, indicat-
ing that this site is essential for gene expression [30]. In this
study, however, we have shown that the critical proximal
SF1 binding site is not responsible for line-specific regula-
tion of the GnRHR gene in swine (Fig. 2).
Identification of an NF-κB site involved in line-specific
expression of the porcine GnRHR gene in gonadotrope
cells is unique. While NF-κB has traditionally been asso-
ciated with genes involved in immune and inflammatory
responses [44], it has been implicated in mediating the
apoptotic effects of GnRH in ovarian cancer cells [45].
As reviewed by Hayden and Ghosh [46], NF-κB typically
exists as a heterodimer composed of p65 (RelA), p50,
p52, RelB and/or c-Rel. Although p52/p65 and p52/RelB
heterodimers are prevalent, most commonly the hetero-
dimer is comprised of the p65 and p50 subunits. Previ-
ously we reported that p52/p65 subunits are involved in
the transcriptional regulation of the porcine GnRHR2
gene in the testis [47]. Regarding gonadotrope cells of
the anterior pituitary gland, however, NF-κB remains no-
ticeably absent from the cast of transcription factors
known to regulate the GnRHR or gonadotropin subunit
genes. In this study, we detected p52 and p65 proteins
within αT3-1 nuclear extracts and established the role of
p52/p65 heterodimer binding in transcriptional regula-
tion of the GnRHR gene. Consistent with this, NF-κB is
an important regulator of Cox-2 promoter activity in the
gonadotrope-derived cell line, LβT2, and treatment with
GnRH stimulated phosphorylation of the p65 subunit by
22-fold [48]. In addition, NF-κB binding sites have also
been associated with regulation of genes expressed in
other pituitary cell types including somatotropes [49]
and corticotropes [50].
The −1240/−1230 region of the Meishan GnRHR pro-
moter also appears to bind another transcription factor
capable of interacting with the SP1 consensus binding
site. Although the use of an SP1 consensus oligonucleo-
tide revealed competition for DNA-protein binding
(Fig. 4), the inability of SP1-specific antibodies acquired
from two separate commercial vendors to bind the
DNA-protein complex (Fig. 4) suggests that an alterna-
tive transcription factor recognizes the SP1 consensus
binding sequence. To further verify the integrity of the
antibodies directed against SP1, we also performed
EMSAs with αT3-1 nuclear extracts and radiolabeled
oligonucleotide containing consensus binding sites for
SP1. In this instance, a specific complex was formed and
the addition of SP1-specific antibodies resulted in super-
shifted DNA-protein complexes (data not shown), con-
firming the presence of SP1 in nuclei of αT3-1 cells and
effectiveness of the SP1 antibodies. Another concern was
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Fig. 10 A bp substitution (G→ T) located at −845 of the Meishan
promoter allows GATA-4 to bind. a Oligonucleotide probes (5’ to 3’)
were synthesized containing sequence flanking a naturally occurring
point mutation at −845 of the Control/Index (C/I −855/−835) and −843
of the Meishan (M −853/−833) promoter. Underlines within each DNA
probe represent the nucleotide substitution between lines and the
putative GATA element (TGATAT; Red) identified by sequence analysis is
highlighted. b EMSAs were performed by incubating radiolabeled
oligonucleotides with nuclear extracts (5 μg) from αT3-1 cells and
specificity of DNA-protein interactions was assessed by competition with
50-fold molar excess of homologous or heterologous unlabeled DNA
(specific complexes indicated by arrows). Additionally, the DNA-protein
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unlabeled oligonucleotides containing consensus binding sequences
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whether the SP1 consensus oligonucleotides actually
contained one or more NF-κB elements and therefore,
was merely mimicking the NF-κB consensus oligonucleo-
tide. However, sequence analysis of the oligonucleotide
containing consensus SP1 binding sites did not reveal any
NF-κB elements. Next, we examined other members of
the SP1 family of transcription factors. Of primary inter-
est, SP3 and SP4 recognize the same binding sequence
with similar affinities [51]. However, the addition of anti-
bodies directed against SP2, SP3 and SP4 were unable to
bind to the specific complex. Thus, we were able to elim-
inate SP1-4 as potential transcription factors binding to
the SP1 element located within −1240/−1230 of the
Meishan GnRHR promoter. Currently, nine members of
the SP1 family (SP1-9) have been identified [52, 53], and
represent a subgroup of a larger class of transcription fac-
tors, the SP1-like/Krüppel-like factor (KLF) family [54].
These factors share a highly conserved DNA-binding do-
main containing three Cys2/His2 zinc fingers [51], which is
the most abundant transcription factor motif in the hu-
man genome [55]. In fact, over 25 SP1-like/KLF genes
have been reported in mammals [56]. The nine SP tran-
scription factors can further be divided into the SP1-like
family (SP1-4) and SP8-like family (SP5-9) [57]. While SP1
and SP3 are ubiquitously expressed, SP5-9 expression pat-
terns are more specific and temporal. SP5 and SP8 expres-
sion has been linked with Wnt activity and are important
for stem cell differentiation and early embryonic develop-
ment [58, 59]. SP6, also known as epiprofin, is involved in
epidermal differentiation [60] whereas SP7, known as
osterix, is expressed in osteoblasts [61]. Additionally, SP9
is also expressed embryonically and affects limb outgrowth
[62]. Given the developmental roles that SP5-9 frequently
play, it is unlikely that any of these factors are binding the
GnRHR gene promoter. Thus, more studies are required
to determine the identity of the factor(s) binding to the
SP1 site within the −1240/−1230 promoter region of the
Meishan GnRHR gene.
Mutation of the individual binding sites for NF-κB and
the SP1-like factor within the Meishan GnRHR promoter
demonstrated a significant loss of promoter activity.
In addition, mutation of both the NF-κB and the SP1
recognition sequences (−Mμ1240pGL3) diminished lucif-
erase activity to approximately the same level as either sin-
gle block mutation. Due to the lack of further reduction
of luciferase activity by the double block replacement
mutation, it would appear that the transcription factors
binding to the two elements work synergistically, but
not additively, to stimulate increased GnRHR promoter
activity in the Meishan line of swine. Indeed, NF-κB inter-
acts with a variety of other transcription factors including
AP1, estrogen receptor α, C/EBP, SF1 and SP1 [63–66].
The Nabel laboratory determined that SP1 interacts with
p65 via the DNA binding regions of each factor and that
this interaction is necessary for activation of the HIV-1
gene [67]. Despite the importance of the complex of
transcription factors binding at −1240/−1230, none of
the mutations lowered Meishan GnRHR promoter ac-
tivity to that of the native full-length Control promoter
suggesting another element(s) within the Meishan GnRHR
promoter also confers line-specific expression.
We also identified 2 additional single-bp alterations lo-
cated at −845 (G→ T) and at −1690 (T→C) within the
Meishan GnRHR promoter region that allowed binding
of GATA-4 to the recognition sites. While GATA-4 has
not previously been implicated in transcriptional regula-
tion of the GnRHR gene, it is involved in the expression
of other gonadotropic genes. A GATA motif detected
within the human α-subunit gene promoter binds GATA-2
and a GATA-4-related protein in αT3-1 cells [68]. These
investigators were unable to confirm GATA-4 binding be-
cause specific antibodies directed against GATA-4 were not
commercially available at the time. Consistent with these
results, our study confirmed the presence of GATA-4 in
gonadotrope-derived αT3-1 cells and implicated its import-
ance in regulation of gonadotropic gene expression. Steger
and coworkers [68] also reported that the same GATA
element binds GATA-2 and -3, but not GATA-4-related
protein, in placental-derived cell lines. Binding of GATA-4
also regulates other genes essential to reproduction [69]. In
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Fig. 11 Mutation of the Meishan-specific GATA-4 binding site diminished promoter activity in αT3-1 cells. Cells were transiently transfected with
luciferase (LUC) vectors containing either the native, full-length Meishan promoter (−M5118pGL3), a block replacement mutation of the GATA-4
binding site within the context of −M5118pGL3 (−MμGATA4pGL3), or promoterless control (pGL3). Unique letters indicate means that are signifi-
cantly different from one another (P < 0.05)
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the neuronal GT1-7 cell line, GATA-4 binds recognition
sites within the promoter for the GnRH gene [70]. Tran-
scription of the Müllerian inhibiting substance (MIS) gene
in Sertoli cells is enhanced by the direct interaction of
GATA-4 and SF1, although GATA-4 binding to the DNA is
not required for this synergistic effect [71, 72]. Additionally,
adrenal-specific transcription of the human P450c17 gene
is regulated by the interaction of GATA-4 or GATA-6 with
SP1 [73]. However, despite its contribution to enhanced
promoter activity of the Meishan GnRHR gene, the GATA-
4 binding sites, like the NF-κB and SP1 elements, do not
fully explain the increased activity of reporter constructs
containing the Meishan compared to Control/Index pro-
moters. Therefore, future studies in our laboratory will
focus on identifying the remaining elements and corre-
sponding binding factors that contribute to the enhanced
activity of the Meishan GnRHR promoter in αT3-1 cells.
Conclusions
In conclusion, the large variance in GnRHR promoter
activity among the Control, Index, and Meishan lines of
swine appears to be due, in part, to binding of the p52
and p65 subunits of NF-κB and a SP1-like transcription
factor that recognizes an SP1 binding sequence within
the Meishan versus Control and Index promoters (Fig. 12).
The NF-κB and SP1 elements within the Control/Index
promoter overlap by a single bp (−1235), preventing bind-
ing of the protein complex. However, the polymorphism
(C→G) specific to the Meishan promoter shifts the SP1
site 3’ by 1 bp, allowing it to abut with the NF-κB element,
thereby conferring binding of the protein complex to the
recognition sequences. Another polymorphism (G→T)
located at −845 of the Meishan GnRHR promoter binds
GATA-4, enhancing its activity in αT3-1 cells compared
to the Control or Index promoters (Fig. 12). An additional
distal polymorphism (−1690) within the upstream enhan-
cer allows GATA-4 to bind to the Meishan promoter,
whereas the p52 and p65 subunits of NF-κB bind to the
homologous Control/Index promoters (Fig. 12). There-
fore, the 3 identified elements unique to the Meishan pro-
moter contribute to its enhanced activity over the
Control/Index promoters. These data illustrate the alter-
native mechanisms employed by the Meishan line of swine
to regulate GnRHR gene expression in gonadotropes. To
our knowledge, this represents the first report of genetic
polymorphisms within the 5’ flanking sequence of the
GnRHR gene that directly result in divergent promoter ac-
tivity. Furthermore, we demonstrated a unique role for the
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Fig. 12 Diagrammatic model of the GnRHR gene promoters from the Meishan and Control/Index lines of swine. Within the upstream enhancer
region, a bp substitution (T→ C) next to the 22-bp deletion results in a functional GATA-4 site in the Meishan promoter, however, a neighboring NF-κB
site in the control promoter binds the p52 and p65 subunits of NF-κB in the absence of GATA-4 binding. A single-bp substitution (C→G) at −1232 in the
Meishan compared to Control/Index (−1235) GnRHR gene promoters allows for binding of a complex of transcription factors including the p52 and
p65 subunits of NF-κB and a SP1-like protein capable of binding to a SP1 binding site. Interestingly, the NF-κB and SP1 elements within the Control/
Index promoter overlap by a single bp, preventing binding of the protein complex, whereas the polymorphism (C→G) specific to the Meishan
promoter shifts the SP1 site 3’ by 1 bp allowing it to abut the NF-κB element. An additional G→ T bp alteration at −845 of the porcine GnRHR gene
allows for Meishan-specific binding of GATA-4. An RXR binding site at −279/−274 and three SF1 binding sites (GSE) at −179/−171, −315/−310
and −1760/−1753 are members of the gonadotrope-specific promoter for the porcine GnRHR gene [30] and therefore, common to both lines
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NF-κB family of transcription factors in transcriptional
regulation of the GnRHR gene within gonadotropes of the
anterior pituitary gland.
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